Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.

The studies described in this report demonstrate that 1-adamantanamine hydrochloride (amantadine) is a potent enhancer of the cytotoxic activity of the anti-pan-T lymphocyte (CD5) T101 monoclonal antibody conjugated to purified ricin A-chain (T101-immunotoxin; T101-IT). We also demonstrate that T101-IT in the presence of amantadine does not induce immunotoxin-mediated cytotoxicity in nontarget cells such as human marrow hematopoietic progenitor cells. These results provide further knowledge for the improvement of ex vivo purification of human bone marrow from normal or leukemic T cells prior to allogeneic or autologous stem cell transplantation, respectively. Furthermore, since amantadine has long been employed safely in human therapy, its use in conjunction with immunotoxins might be exploited in vivo.

[1]  G. Bonadonna,et al.  SPECIFIC EX‐VIVO DEPLETION OF HUMAN BONE MARROW T LYMPHOCYTES BY AN ANTI‐PAN‐T CELL (CD5) RICINA‐CHAIN IMMUNOTOXIN , 1987, Transplantation.

[2]  B. Dupont,et al.  Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. , 1986, Blood.

[3]  A. Schwartz,et al.  Receptor-mediated endocytosis. , 1985, The Biochemical journal.

[4]  A. Schwartz,et al.  Receptor-mediated endocytosis. , 1986, The Journal of clinical investigation.

[5]  B. Dupont,et al.  QUANTITATION OF T LYMPHOCYTES IN HUMAN BONE MARROW BY A LIMITING DILUTION ASSAY , 1985, Transplantation.

[6]  F. Hayden,et al.  Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults , 1985, Antimicrobial Agents and Chemotherapy.

[7]  J. Hansen,et al.  Quantitative assays for detection of residual T cells of T-depleted human marrow. , 1985, Blood.

[8]  B. Clarkson,et al.  Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow. , 1985, Blood.

[9]  P. Casellas,et al.  Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxin. , 1985, Blood.

[10]  J. Hansen,et al.  A ricin A chain-containing immunotoxin that kills human T lymphocytes in vitro. , 1985, Blood.

[11]  V. Raso,et al.  Carboxylic ionophores enhance the cytotoxic potency of ligand- and antibody-delivered ricin A chain , 1984, The Journal of experimental medicine.

[12]  H. Broxmeyer,et al.  Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin. , 1984, Journal of immunology.

[13]  P. Casellas,et al.  Kinetics of Cytotoxicity Induced by Immunotoxins , 1984 .

[14]  I. Pastan,et al.  Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Dominique,et al.  Immunotoxins: Hybrid Molecules Combining High Specificity and Potent Cytotoxicity , 1982, Immunological reviews.

[16]  A controlled trial of amantadine and rimantadine in the prophylaxis of Influenza A infection , 1982 .

[17]  D. Richman,et al.  The intracellular distribution and antiviral activity of amantadine. , 1981, Virology.

[18]  C. Taswell,et al.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.

[19]  I. Royston,et al.  Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. , 1980, Journal of immunology.

[20]  B Poole,et al.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. , 1978, Proceedings of the National Academy of Sciences of the United States of America.